期刊文献+

紫外分光光度法测定注射用西维来司他钠的含量

Assay of sivelestat sodium hydrate for injection by UV spectrophotography
下载PDF
导出
摘要 目的建立紫外分光光度测定注射用西维来司他钠含量的方法。方法据中国药典2005年版二部附录ⅣA,以0.01mol·L^-1氢氧化钠甲醇溶液为溶剂。测定波长325nm。结果在10~150μg·mL^-1浓度范围内,吸收度-5相应的浓度呈良好的线性关系(r=0.9999)。重复测定吸收度平均值为0.4441(n=6).相对标准偏差为0.46%。平均回收率为99.9%(n=9),相对标准偏差为0.6%。结论本方法结果稳定,重复性好。为注射用西维来司他钠提供了一个简单方便的含量测定方法。 OBJECTIVE To establish the assay method for sivelestat sodium hydrate for injection by UV spectrophotography.METHODS According to the Appendix Ⅳ A in Chinese Pharmacopeia 2005, 0.01mol·L^-1 sodium hydroxide methanol was used as solvent, and detected at the wavelength of 325nm. RESULTS There was a quite good linear relationship between adsorption value and the concentrations (r= 0. 9999)during 10-150μg·mL^-1.The mean adsorption value was 0.4441 and RSD was 0.46% by the repeat determination (n= 6).The mean recovery rate was 99.9 % (n = 9), and the RSD was 0.6 %. CONCLUSION The results of this method are stable and have good repeatability. It provides an easy method for the content determination of sivelestat sodium hydrate for injection.
出处 《海峡药学》 2008年第7期62-63,共2页 Strait Pharmaceutical Journal
关键词 注射用西维来司他钠 含量测定 紫外分光光度法 Sivelestat sodium hydrate for injection Assay UV spectrophotography
  • 相关文献

参考文献5

二级参考文献33

  • 1郭炼伟,张灿.西维来司钠的合成[J].药学进展,2005,29(2):85-87. 被引量:2
  • 2WAN S,LECLERE J L,VIVCENT J L.Inflammatory response to cardiopulmonary bypass:mechanisms involved and possible therapeutic strategies[J].Chest,1997,112(3):676-692.
  • 3KAWABATA K,HAGIO T,MATSUOKA S.Pharmacological profile of a specific neutrophil elastase inhibitor,Sivelestat sodium hydrate[J].Nippon Yakurigaku Zasshi,2003,122(2):151-160.
  • 4MORAES T J,CCOW C W,DOWNEY G P.Proteases and lung injury[J].Crit Care Med,2003,31(4 Suppl):S189-S194.
  • 5Zeiher BG, Matsuoka S, Kawabata K, et aL Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Crit Care Med, 2002, 30 (5 Suppl) :S281-S287.
  • 6Hagio T, Nakao S, Matsuoka H, et al. Inhibition of neutrophil elastase activity attenuates complement-mediated lung injury in the hamster. Eur J Pharmaco1,2001,426 : 131-138.
  • 7Jochum M,Gippner-Steppert C, Machleidt W, et al. The role of phagocyte proteinases and proteinase inhibitors in multiple organ failure[J]. Am J Respir Crit Care Med, 1994, 150 (Suppl):S123 - S130.
  • 8Sakamaki F, Ishizaka A,Urano T, et al. Effect of a specific neutrophil elastase inhibitor,ONO-5046 ,on endotoxin-induced acute lung injury[J]. Am J Respir Crit Care Med, 1996, 153(1):391 - 397.
  • 9Kubo K,Kobayashi T,Hayano T, et al. Effects of ONO-5046,a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep[J]. J Appl Physiol, 1994,77(3): 1333 - 1340.
  • 10Miyazaki H, Yamada H. Pretreatment of acid-induced lung injury with specific neutrophil elastase inhibitor ONO-5046 did not exasperate the subsequent bacterial lung infection by pseudomonas aeruginosa [J]. Masui, 2000,49 (7): 724 - 73 1.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部